Interim report January – September 2019
Continued positive growth in Accessibility. Patient Handling Institutional US and Brexit uncertainties impact revenues. The Board has initiated a strategic review aimed to uncover underlying value Third quarter 2019 · Revenue amounted to MEUR 65.6 (65.2) · Organic growth was 0.2% (0.4) · The gross margin was 41.2% (44.0) · Adjusted EBITA amounted to MEUR 4.7 (5.9), corresponding to a margin of 7.2% (9.1) · EBIT amounted to MEUR 3.2 (4.5), corresponding to a margin of 4.9% (6.9) · Net profit (including discontinued operations) amounted to MEUR 3.9 (3.5) · Earnings